Shares of Gerresheimer rose 18.5% to €20.98 after 96% of €870 m promissory note holders extended filing deadline to 30 Sept 2026.
Banking partners also granted parallel extensions and waived key debt‑ratio covenants through Q3, easing immediate financial distress risk.
Company launched a sale process for U.S. subsidiary Centor, attracting double‑digit party interest with a deal expected before year‑end.
Bernstein analysts note improved sentiment but warn covenant renegotiation costs could rise €10‑20 m above €100 m estimate and restructuring scope remains unclear.